Abiopharma

🔍 Catarisano Nancy E. (Director)

Company: TOMPKINS FINANCIAL CORP (TMP)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 111 shares of Phantom Stock (Derivative)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,018.32 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Acquired 370 shares of Phantom Stock (Derivative)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,906.89 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: Each share of phantom stock is the economic equivalent of one share of common stock. Phantom stock represents deferred stock compensation under the Amended and Restated Retainer Plan for Eligible Directors of Tompkins Financial Corporation and its Wholly-Owned Subsidiaries. These shares are held in a rabbi trust pending distribution upon the occurrence of certain events specified in the Plan. The reporting person has no voting or investment power over the shares prior to such distribution.